1. Market Research
  2. > Biotechnology
  3. > Medical Biotechnology Market Trends
Biopharmaceutical R&D Productivity 2016

Biopharmaceutical R&D Productivity 2016

  • January 2016
  • ID: 5499354
  • Format: PDF
  • By I2DB

Summary

"On the morning of the 16th of July, I was stationed at the Base Camp at Trinity in a position about ten miles from the site of the explosion

The explosion took place at about 5:30 A.M. I had my face protected by a large board in which a piece of dark welding glass had been inserted. My first impression of the explosion was the very intense flash of light, and a sensation of heat on the parts of my body that were exposed. Although I did not look directly towards the object, I had the impression that suddenly the countryside became brighter than in full daylight. I subsequently looked in the direction of the explosion through the dark glass and could see something that looked like a conglomeration of flames that promptly started rising. After a few seconds the rising flames lost their brightness and appeared as a huge pillar of smoke with an expanded head like a gigantic mushroom that rose rapidly beyond the clouds probably to a height of the order of 30,000 feet. After reaching its full height, the smoke stayed stationary for a while before the wind started dispersing it.

About 40 seconds after the explosion the air blast reached me. I tried to estimate its strength by dropping from about six feet small pieces of paper before, during and after the passage of the blast wave. Since, at the time, there was no wind I could observe very distinctly and actually measure the displacement of the pieces of paper that were in the process of falling while the blast was passing. The shift was about 2 ½ meters, which, at the time, I estimated to correspond to the blast that would be produced by ten thousand tons of T.N.T. "

The above passage is Enrico Fermi’s eyewitness account of the Trinity plutonium bomb test, which took place on July 16, 1945. Nearly a week would pass before an official estimate of the bomb’s yield – using data gathered by two lead-lined tanks, fifty beryllium-copper microphones, plus numerous seismographs, gamma ray detectors, neutron detectors and mechanical pressure gauges – would show Fermi’s on-the-spot estimate to be roughly correct

The Trinity test is perhaps the most dramatic example of what has come to be known as a Fermi question – a question for which no immediately available precise answer exists, but whose answer can be approximated well enough to allow immediately useful action

R&D productivity is a Fermi question. Tracing the economic returns of a discovery from the moment an idea forms in a scientist’s head until the last pill’s sold is as unnecessary as it is unlikely. The same goes for a comprehensive, finely calibrated inventory of all factors that aid or impair productivity

We need only enough data to take informed and effective action – and sufficient data currently exists. Yet despite the availability of this information, much of the decline in R&D productivity can be traced to unforced errors made by managers lacking (awareness of) relevant information

In this study we’ve measured – in every useful way we can imagine — the R&D productivity of the 22 largest (by R&D spending) US-listed biopharmaceutical companies. Our measures are neither perfect, nor complete – but they are more than adequate to inform immediate and effective actions. Notably, all of the data used in our metrics is publicly disclosed, in one form or another, by the companies themselves – like scraps of paper that blow in the wind. All that’s required is to pick them up and have a careful look…

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2019

Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2019, provides ...

Ischemia Reperfusion Injury - Pipeline Review, H2 2019

Ischemia Reperfusion Injury - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Ischemia Reperfusion Injury - Pipeline Review, H2 2019SummaryPharmaceutical and Healthcare disease pipeline guide Ischemia Reperfusion Injury - Pipeline Review, H2 2019, provides an overview of the Ischemia ...

Global Immunology Partnering 2014-2019: Deal trends, players and financials

Global Immunology Partnering 2014-2019: Deal trends, players and financials

  • $ 2995
  • December 2019

Global Immunology Partnering 2014 to 2019 provides the full collection of Immunology disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014.Trends in Immunology ...


ref:plp2016

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on